Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gelli

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Veterinary Research Communications|March 29, 2022
Clinical use of Anti-Müllerian Hormone to monitor resumption of ovarian activity following removal of a 4.7 mg deslorelin implant in queensL Ferré-Dolcet, S Ferro, B Contiero, et al.
Clinical Genetics|October 1, 1996
FISH characterization of the Xq21 breakpoint in a translocation carrier with premature ovarian failureP Riva, I Magnani, A M Fuhrmann Conti, et al.
Journal of Wildlife Diseases|July 21, 2009
Serum biochemistry and electrophoretic patterns in the Eurasian Buzzard (Buteo buteo): reference valuesD Gelli, V Ferrari, F Franceschini, et al.
Acta Europaea Fertilitatis|July 1, 1987
Induction of ovulation with pulsatile GnRH: comparison between subcutaneous and intravenous administration in the same patientsA Riolo, E Carioni, S Lerro, et al.
Reproduction in Domestic Animals = Zuchthygiene|September 17, 2009
Clinical use of testicular fine needle aspiration cytology in oligozoospermic and azoospermic dogsS Romagnoli, P Bonaccini, C Stelletta, et al.
European Journal of Endocrinology|December 16, 1998
Cabergoline in acromegaly: a renewed role for dopamine agonist treatment?R Cozzi, R Attanasio, M Barausse, et al.
Theriogenology|October 28, 2024
Duration of efficacy and effect of implant location in adult queens treated with a 9.4 mg deslorelin subcutaneous implantA Baldan, M Pereira, V Pedrotti, et al.
Panminerva Medica|April 1, 1980
Neuroactive drugs in endocrine diseases: notes on their physiopathological and therapeutical aspectsG F Silvestrini, D Gelli, A Liuzzi, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Veterinary Research Communications|March 29, 2022
Clinical use of Anti-Müllerian Hormone to monitor resumption of ovarian activity following removal of a 4.7 mg deslorelin implant in queensL Ferré-Dolcet, S Ferro, B Contiero, et al.
Clinical Genetics|October 1, 1996
FISH characterization of the Xq21 breakpoint in a translocation carrier with premature ovarian failureP Riva, I Magnani, A M Fuhrmann Conti, et al.
Journal of Wildlife Diseases|July 21, 2009
Serum biochemistry and electrophoretic patterns in the Eurasian Buzzard (Buteo buteo): reference valuesD Gelli, V Ferrari, F Franceschini, et al.
Acta Europaea Fertilitatis|July 1, 1987
Induction of ovulation with pulsatile GnRH: comparison between subcutaneous and intravenous administration in the same patientsA Riolo, E Carioni, S Lerro, et al.
Reproduction in Domestic Animals = Zuchthygiene|September 17, 2009
Clinical use of testicular fine needle aspiration cytology in oligozoospermic and azoospermic dogsS Romagnoli, P Bonaccini, C Stelletta, et al.
European Journal of Endocrinology|December 16, 1998
Cabergoline in acromegaly: a renewed role for dopamine agonist treatment?R Cozzi, R Attanasio, M Barausse, et al.
Theriogenology|October 28, 2024
Duration of efficacy and effect of implant location in adult queens treated with a 9.4 mg deslorelin subcutaneous implantA Baldan, M Pereira, V Pedrotti, et al.
Panminerva Medica|April 1, 1980
Neuroactive drugs in endocrine diseases: notes on their physiopathological and therapeutical aspectsG F Silvestrini, D Gelli, A Liuzzi, et al.
Pageof 2